Cargando…
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280033/ https://www.ncbi.nlm.nih.gov/pubmed/37346822 http://dx.doi.org/10.12688/wellcomeopenres.18735.2 |
_version_ | 1785060718048968704 |
---|---|
author | Hopcroft, Lisa E. Curtis, Helen J. Brown, Andrew D. Hulme, William J. Andrews, Colm D. Morton, Caroline E. Inglesby, Peter Morley, Jessica Mehrkar, Amir Bacon, Sebastian C. Eggo, Rosalind M. Mahalingasivam, Viyaasan Parker, Edward P. K. Tomlinson, Laurie A. Bates, Christopher Cockburn, Jonathan Parry, John Hester, Frank Harper, Sam Goldacre, Ben Walker, Alex J. MacKenna, Brian |
author_facet | Hopcroft, Lisa E. Curtis, Helen J. Brown, Andrew D. Hulme, William J. Andrews, Colm D. Morton, Caroline E. Inglesby, Peter Morley, Jessica Mehrkar, Amir Bacon, Sebastian C. Eggo, Rosalind M. Mahalingasivam, Viyaasan Parker, Edward P. K. Tomlinson, Laurie A. Bates, Christopher Cockburn, Jonathan Parry, John Hester, Frank Harper, Sam Goldacre, Ben Walker, Alex J. MacKenna, Brian |
author_sort | Hopcroft, Lisa E. |
collection | PubMed |
description | Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and children in England by August 2022. Methods: With the approval of NHS England, a cohort study was conducted of 3.21 million children and adolescents’ records in general practice in England, in situ and within the infrastructure of the electronic health record software vendor TPP using OpenSAFELY. Vaccine coverage across various demographic (sex, deprivation index and ethnicity) and clinical (risk status) populations is described. Results: Coverage is higher amongst adolescents than it is amongst children, with 53.5% adolescents and 10.8% children having received their first dose of the COVID-19 vaccine. Within those groups, coverage varies by ethnicity, deprivation index and risk status; there is no evidence of variation by sex. Conclusion: First dose COVID-19 vaccine coverage is shown to vary amongst various demographic and clinical groups of children and adolescents. |
format | Online Article Text |
id | pubmed-10280033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-102800332023-06-21 First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY Hopcroft, Lisa E. Curtis, Helen J. Brown, Andrew D. Hulme, William J. Andrews, Colm D. Morton, Caroline E. Inglesby, Peter Morley, Jessica Mehrkar, Amir Bacon, Sebastian C. Eggo, Rosalind M. Mahalingasivam, Viyaasan Parker, Edward P. K. Tomlinson, Laurie A. Bates, Christopher Cockburn, Jonathan Parry, John Hester, Frank Harper, Sam Goldacre, Ben Walker, Alex J. MacKenna, Brian Wellcome Open Res Research Note Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and children in England by August 2022. Methods: With the approval of NHS England, a cohort study was conducted of 3.21 million children and adolescents’ records in general practice in England, in situ and within the infrastructure of the electronic health record software vendor TPP using OpenSAFELY. Vaccine coverage across various demographic (sex, deprivation index and ethnicity) and clinical (risk status) populations is described. Results: Coverage is higher amongst adolescents than it is amongst children, with 53.5% adolescents and 10.8% children having received their first dose of the COVID-19 vaccine. Within those groups, coverage varies by ethnicity, deprivation index and risk status; there is no evidence of variation by sex. Conclusion: First dose COVID-19 vaccine coverage is shown to vary amongst various demographic and clinical groups of children and adolescents. F1000 Research Limited 2023-06-09 /pmc/articles/PMC10280033/ /pubmed/37346822 http://dx.doi.org/10.12688/wellcomeopenres.18735.2 Text en Copyright: © 2023 Hopcroft LE et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Note Hopcroft, Lisa E. Curtis, Helen J. Brown, Andrew D. Hulme, William J. Andrews, Colm D. Morton, Caroline E. Inglesby, Peter Morley, Jessica Mehrkar, Amir Bacon, Sebastian C. Eggo, Rosalind M. Mahalingasivam, Viyaasan Parker, Edward P. K. Tomlinson, Laurie A. Bates, Christopher Cockburn, Jonathan Parry, John Hester, Frank Harper, Sam Goldacre, Ben Walker, Alex J. MacKenna, Brian First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title | First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title_full | First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title_fullStr | First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title_full_unstemmed | First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title_short | First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY |
title_sort | first dose covid-19 vaccine coverage amongst adolescents and children in england: an analysis of 3.21 million patients' primary care records in situ using opensafely |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280033/ https://www.ncbi.nlm.nih.gov/pubmed/37346822 http://dx.doi.org/10.12688/wellcomeopenres.18735.2 |
work_keys_str_mv | AT hopcroftlisae firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT curtishelenj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT brownandrewd firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT hulmewilliamj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT andrewscolmd firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT mortoncarolinee firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT inglesbypeter firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT morleyjessica firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT mehrkaramir firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT baconsebastianc firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT eggorosalindm firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT mahalingasivamviyaasan firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT parkeredwardpk firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT tomlinsonlauriea firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT bateschristopher firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT cockburnjonathan firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT parryjohn firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT hesterfrank firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT harpersam firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT goldacreben firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT walkeralexj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely AT mackennabrian firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely |